Traders purchased shares of CVS Health (NYSE:CVS) on weakness during trading hours on Friday. $100.28 million flowed into the stock on the tick-up and $50.68 million flowed out of the stock on the tick-down, for a money net flow of $49.60 million into the stock. Of all stocks tracked, CVS Health had the 24th highest net in-flow for the day. CVS Health traded down ($0.24) for the day and closed at $65.12
A number of equities research analysts recently issued reports on the company. Leerink Swann set a $85.00 price objective on CVS Health and gave the stock a “buy” rating in a research report on Tuesday, April 10th. ValuEngine downgraded CVS Health from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Vetr downgraded CVS Health from a “buy” rating to a “hold” rating and set a $77.11 price objective on the stock. in a research report on Thursday, January 4th. Morgan Stanley upgraded CVS Health from an “equal weight” rating to an “overweight” rating and set a $88.00 price objective on the stock in a research report on Friday, January 5th. Finally, SunTrust Banks increased their price objective on CVS Health to $90.00 and gave the stock a “buy” rating in a research report on Friday, January 5th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $86.65.
The company has a market cap of $66,066.33, a PE ratio of 11.00, a PEG ratio of 1.11 and a beta of 1.05. The company has a quick ratio of 0.52, a current ratio of 1.02 and a debt-to-equity ratio of 0.59.
CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.88 by $0.04. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The firm had revenue of $48.39 billion for the quarter, compared to analysts’ expectations of $47.54 billion. During the same period last year, the firm earned $1.71 earnings per share. The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. equities analysts predict that CVS Health will post 6.32 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 3rd. Stockholders of record on Monday, April 23rd will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, April 20th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.07%. CVS Health’s dividend payout ratio (DPR) is currently 33.90%.
In other news, EVP Helena Foulkes sold 19,965 shares of the firm’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $71.04, for a total transaction of $1,418,313.60. Following the transaction, the executive vice president now directly owns 65,072 shares of the company’s stock, valued at $4,622,714.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.61% of the stock is currently owned by company insiders.
Large investors have recently made changes to their positions in the company. Wealthcare Advisory Partners LLC grew its stake in shares of CVS Health by 330.3% during the third quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock valued at $105,000 after buying an additional 991 shares during the last quarter. Fieldpoint Private Securities LLC grew its stake in shares of CVS Health by 333.3% in the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 1,000 shares during the last quarter. Wagner Wealth Management LLC bought a new stake in shares of CVS Health in the fourth quarter worth about $114,000. IFG Advisory LLC bought a new stake in shares of CVS Health in the fourth quarter worth about $1,504,000. Finally, Focused Wealth Management Inc grew its stake in shares of CVS Health by 90.5% in the fourth quarter. Focused Wealth Management Inc now owns 1,781 shares of the pharmacy operator’s stock worth $129,000 after purchasing an additional 846 shares during the last quarter. 83.97% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION WARNING: This report was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/04/22/traders-buy-shares-of-cvs-health-cvs-on-weakness.html.
CVS Health Company Profile
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.